Logo Image
News
Watch
Expert ConversationsShows & PodcastsNews & Analysis
Conference
Conference CoverageConference Listing
Publication
More
CME/CE
Partners
Resources
Interactive ToolsSpecial ProjectsSponsored
Contribute
Antibiotics Deconstructed
Clinical Forum Insights

Subscribe

  • News
  • Watch
  • Conference
  • Publication
  • CME/CE
  • Partners
  • Resources
  • Contribute
  • Subscribe
  • Clinical Forum Insights
  • Antimicrobial Stewardship
  • Blood-Borne Diseases
    • Ebola
    • HCV / Hepatitis
  • Coronavirus / COVID
  • Food Borne Infection / Food Safety
    • E. Coli
    • Food Safety
    • Listeria
    • Salmonella
  • Fungal Infections
    • Candida auris
  • Gastrointestinal Infections
    • C. Difficile
    • H. Pylori
    • Norovirus
  • Healthcare Associated Infections (HAI)
  • Prevention
    • Antibiotics
    • Immunizations
    • Vaccines
  • Respiratory Infections
    • Community-Acquired Pneumonia
    • Measles
    • Influenza
  • Sexually Transmitted Diseases
    • HIV / AIDS
    • HPV
    • HSV
    • PrEP
  • Skin & Soft Tissue Diseases
    • MRSA
  • Zoonotic & Vector-Borne Diseases
    • Lyme Disease
    • ZIKA
Spotlight -
Vaccines in America|
Antibiotics Deconstructed|
Bench to Bedside With SIDP|
Antimicrobial Stewardship|
Hepatitis
Advertisement

Lauren A. Igneri, PharmD, BCPS, BCCCP

Advertisement

Articles by Lauren A. Igneri, PharmD, BCPS, BCCCP

More Than Surviving Sepsis: Everything Old Is New Again

ByLauren A. Igneri, PharmD, BCPS, BCCCP
June 3rd 2019

Investigators are dusting off angiotensin II and ascorbic acid for renewed use in treating sepis and septic shock.

Advertisement

Latest Updated Articles

  • More Than Surviving Sepsis: Everything Old Is New Again
    More Than Surviving Sepsis: Everything Old Is New Again

    June 3rd 2019



Advertisement
Advertisement

Trending on Contagion Live

1

On World Rabies Day, When to Seek Treatment, Clinical Considerations for Post Exposure Prophylaxis

2

VYD2311 Shows Superior Tolerability to mRNA COVID-19 Vaccine in Phase 3 Study

3

Further Insights, Treatment Considerations Around the PETERPEN Study

4

IDSA/ESCMID Statement on Staphylococcus aureus: Follow-Up Blood Cultures

5

New IDSA/ESCMID S aureus Bacteremia Consensus Statements: a Risk Stratification Framework

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Information
  • Privacy
  • Terms & Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contagion Live
  • CGT Live
  • Neurology Live
  • HCP Live
  • Oncology Live
  • Contemporary Pediatrics
  • Contemporary OBGYN
  • Urology Times
  • The Educated Patient
  • Patient Care Online
HCP Live Network
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us